Abstract

Antiretroviral therapy (ART) effectively reduces cycles of viral replication but does not target proviral populations in cells that persist for prolonged periods and that can undergo clonal expansion. Consequently, chronic human immunodeficiency virus (HIV) infection is sustained during ART by a reservoir of long-lived latently infected cells and their progeny. This proviral landscape undergoes change over time on ART. One of the forces driving change in the landscape is the clonal expansion of infected CD4 T cells, which presents a key obstacle to HIV eradication. Potential mechanisms of clonal expansion include general immune activation, antigenic stimulation, homeostatic proliferation, and provirus-driven clonal expansion, each of which likely contributes in varying, and largely unmeasured, amounts to maintaining the reservoir. The role of clinical events, such as infections or neoplasms, in driving these mechanisms remains uncertain, but characterizing these forces may shed light on approaches to effectively eradicate HIV. A limited number of individuals have been cured of HIV infection in the setting of bone marrow transplant; information from these and other studies may identify the means to eradicate or control the virus without ART. In this review, we describe the mechanisms of HIV-1 persistence and clonal expansion, along with the attempts to modify these factors as part of reservoir reduction and cure strategies.

Highlights

  • While Antiretroviral therapy (ART) reduces the morbidity and mortality associated with a decline in CD4 T cells and the progression to AIDS, ART does not result in a cure [4,5,6], and human immunodeficiency virus (HIV) persistence represents the most important obstacle preventing the eradication of virus infection or viral control without

  • Rebound viremia arises from an HIV reservoir, defined here as a population of cells infected with replication-competent HIV virus

  • HIVincompetent proviruses may produce HIV RNA and protein, which may be recognized by host immune cells, and may contribute to immune activation, which has been correlated with morbidity and mortality during ART [7,8,9]

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rebound viremia arises from an HIV reservoir, defined here as a population of cells infected with replication-competent HIV virus. HIVincompetent proviruses may produce HIV RNA and protein, which may be recognized by host immune cells, and may contribute to immune activation, which has been correlated with morbidity and mortality during ART [7,8,9] Both replication-competent and -incompetent proviruses may contribute to HIV pathogenesis during ART. Several approaches, including “shock-andkill”, “block-and-lock”, ART intensification, and activated CD8 T-cell infusions have been employed in an attempt to reduce reservoirs [10,11,12,13,14] Far, these approaches have had no detectable long-term impact on the replication-competent reservoir. Accessed on 29 November 2021) maintains a detailed discussion of the resistance to each antiretroviral [33]

HIV Replication and Establishing the Proviral State
Response to Antiretroviral Therapy In Vivo
Potential Mechanisms of HIV Persistence
Ongoing Cycles of HIV Replication
Persistence and Clonal Expansion of HIV-Infected Cells
Implications of Persistence Mechanisms
Nucleic Acid Analyses and Bioassayss
Genetic Characterization of HIV Variants
Analysis of Integration Sites
Natural History Studies
Interventional Studies to Assess Ongoing Replication
Proviral Landscape during ART
Target Cells and Anatomic Sites
Specific Anatomic Compartments with HIV-Infected Cells
Implications of Persistence for Cure Strategies
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call